Class I · High risk
Thyroid Tablets
Superpotent Drug
Is Thyroid recalled?
Yes — there is an active recall. 2 ongoing FDA recalls mention Thyroid (65 total). Check the affected lots below.
Most common reason: Wrong potency / content (41 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Thyroid. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Thyroid recalls in 2026
2 initiated in 2026, 65 in total — newest first
Class II · Moderate risk
Thyroid
Subpotent Drug
Class II · Moderate risk
S.P Labs
Failed Stability Specifications
Class II · Moderate risk
S.P.Labs
Failed Stability Specifications
Class II · Moderate risk
Levothyroxine 25mcg in Ns 1.25ml Syringe
Lack of sterility assurance
Class II · Moderate risk
Armour Thyroid
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class I · High risk
NP Thyroid 120 Thyroid Tablets
Subpotent Drug
Class I · High risk
NP Thyroid 90 Thyroid Tablets
Subpotent Drug
Class I · High risk
NP Thyroid 60 Thyroid Tablets
Subpotent Drug
Class I · High risk
NP Thyroid 30 Thyroid Tablets
Subpotent Drug
Class I · High risk
NP Thyroid 15 Thyroid Tablets
Subpotent Drug
Class I · High risk
NP Thyroid 120
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Class I · High risk
NP Thyroid 15
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Class II · Moderate risk
Nature-Throid 1 GR
CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
WP Thyroid
Subpotent Drug: FDA analysis found product to be subpotent
Class II · Moderate risk
WP Thyroid
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.